Novo Nordisk BV

Last updated: 30.09.2015

Novo Bordisk BV

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Headquartered in DenmarkNovo Nordisk employs approximately 40,700 employees in 75 countries, and markets its products in more than 180 countries.

Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).


Novo Nordisk B.V.

Flemingweg 18, 2408 AV Alphen aan den Rijn
T: +31-172 44 94 94




We use cookies to ensure that we give you the best experience on our site. For more info click here